Related Experiment Videos
Survival patterns for malignant mesothelioma: the SEER experience
R Spirtas1, R R Connelly, M A Tucker
1National Cancer Institute, Bethesda, MD 20892.
International Journal of Cancer
|April 15, 1988
Summary
Malignant mesothelioma survival is influenced by age, sex, and disease stage. Younger women experienced longer survival, and asbestos exposure may impact outcomes.
Area of Science:
- Epidemiology
- Oncology
- Biostatistics
Background:
- Malignant mesothelioma is a rare and aggressive cancer.
- Understanding prognostic factors is crucial for patient management and clinical trial design.
Purpose of the Study:
- To identify key predictors of survival in malignant mesothelioma patients.
- To explore the influence of demographic, clinical, and environmental factors on patient outcomes.
Main Methods:
- Statistical analysis of 1,475 histologically confirmed malignant mesothelioma cases.
- Data sourced from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program (1973-1984).
- Evaluation of age, sex, disease stage, treatment, geographic area, and potential asbestos exposure as prognostic factors.
Main Results:
- Age at diagnosis, sex, disease stage, and geographic residence were significant predictors of survival.
- Women under 50 demonstrated unusually long survival, even after adjusting for other variables.
- Survival was shorter in areas with major shipbuilding industries, suggesting a potential link to asbestos exposure.
Conclusions:
- Age, gender, and disease stage are critical factors for designing and analyzing mesothelioma clinical trials.
- Further research is warranted to elucidate the impact of asbestos exposure on mesothelioma survival.
- The findings highlight the need for personalized treatment strategies based on patient and disease characteristics.